By: Kairos Ventures On: September 29, 2017 In: Auspion, Portfolio News

We are thrilled to announce that Auspion Inc. has joined the Kairos Portfolio. Auspion, Inc. is a wireless communications...

Read more

We're excited to share that our portfolio company, Axial Biotherapeutics, has been selected as one of FierceBiotech's Fierce 15...

Read more

We are delighted to announce that Chimera Bioengineering is the latest company to join the Kairos portfolio. Founded in...

Read more

We are pleased to announce that Transient Plasma Systems (TPS) is the latest company to join the Kairos portfolio....

Read more
By: Kairos Ventures On: August 10, 2017 In: Delpor, Portfolio News

Healthline recently published an article on the importance of implantable drugs, including Delpor’s implant devices. The first half of...

Read more

This month, Axial Biotherapeutics announced the appointment of leading experts in the Autism Spectrum Disorders (ASD) field to its...

Read more

We are proud to announce that Kairos Venture Partners II, L.P., our second fund, has made its second investment...

Read more
By: Kairos Ventures On: July 19, 2017 In: 3D Bio, Kairos II, Portfolio News

We are excited to announce that Kairos Venture Partners II, L.P., our second fund, has made its first investment...

Read more
By: Kairos Ventures On: June 25, 2017 In: Kairos News

We would like to welcome six new team members to Kairos Ventures: Danielle Walker, Chris Del Vecchio and Shahed...

Read more
By: Kairos Ventures On: June 22, 2017 In: Compellon, Portfolio News

Kairos portfolio company, Compellon, appointed software and services veteran Carv Moore as its Chief Executive Officer to lead the...

Read more